Venus Concept Inc. (VERO)

Market Cap	2.52M
Revenue (ttm)	61.00M
Net Income (ttm)	-49.57M
Shares Out	1.04M
EPS (ttm)	-71.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	60,107
Open	2.310
Previous Close	2.330
Day's Range	2.282 - 2.430
52-Week Range	2.100 - 17.490
Beta	-0.03
Analysts	n/a
Price Target	n/a
Earnings Date	May 15, 2025

About VERO

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, a portable and fractional RF system for d...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Rajiv Kanishka De Silva
• Employees: 292
• Stock Exchange: NASDAQ
• Ticker Symbol: VERO
• Website: https://www.venus.ai

Financial Performance

In 2024, Venus Concept's revenue was $64.83 million, a decrease of -15.09% compared to the previous year's $76.35 million. Losses were -$47.00 million, 26.2% more than in 2023.